PT  - JOURNAL ARTICLE
AU  - Dominique Jones
AU  - David Faluyi
AU  - Sarah Hamilton
AU  - Nicholas Stylianides
AU  - Ken Ma
AU  - Sarah Duff
AU  - Nicholas Machin
AU  - Richard J Edmondson
TI  - A prospective study to identify rates of SARS-CoV-2 virus in the peritoneum and lower genital tract of patients having surgery
AID  - 10.1101/2020.07.30.20165043
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.07.30.20165043
4099  - http://medrxiv.org/content/early/2020/08/02/2020.07.30.20165043.short
4100  - http://medrxiv.org/content/early/2020/08/02/2020.07.30.20165043.full
AB  - Introduction The risks to surgeons of carrying out aerosol generating procedures during the COVID pandemic are unknown. To start to define these risks, in a systematic manner, we investigated the presence of SARS-CoV-2 virus in the abdominal fluid and lower genital tract of patients undergoing surgery.Methods We carried out a prospective cross sectional observational study of 113 patients undergoing abdominal surgery or instrumentation of the lower genital tract. We took COVID swabs from the peritoneal cavity and from the vagina from all eligible patients. Results were stratified by pre operative COVID status.Results In patients who were presumed COVID negative at the time of surgery SARS-CoV-2 virus RNA was detected in 0/102 peritoneal samples and 0/98 vaginal samples. Peritoneal and vaginal swabs were also negative in one patient who had a positive nasopharyngeal swab immediately prior to surgery.Conclusions The presence of SARS-CoV-2 RNA in the abdominal fluid or lower genital tract of presumed negative patients is nil or extremely low. These data will inform surgeons of the risks of restarting laparoscopic surgery at a time when COVID19 is endemic in the population.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno funding was requiredAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:. The study was registered with the National Institute of Health Research (NIHR) register of COVID related trials. Ethical approval was obtained from Frenchay Research Ethics Committee (20/SW/0088) and informed written consent obtained from all patients prior to the collection of swabs and data. The study was sponsored by Manchester University NHS Foundation Trust.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesno non patient identifiable data are available from this study